Advertisement
|
|
news roundup
Updated employee announcements, business news, awards, and recognition in the industry today.
| Advertisement
Is RBM living up to the hype? The state of RBM in clinical development
Wednesday, June 13, 2018 at 11am EDT
 Register now |
RTI International addresses the challenge of clinical trial informed consent forms by teaming up with Consenter, a patient-engagement platform that solves the problem of clinical trial enrollment by combining communication science with digital, interactive technology.
| Advertisement
The Future of ECOA
Tuesday, June 12, 2018 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST
 Register now |
Elligo Health Research, a clinical research services provider, has launched a Research Ready program for physician practices interested in becoming a study site. This program expands and diversifies clinical trial patient populations because healthcare providers are now able to offer these studies to their patients as a care option.
| Advertisement
Functional Service Models Reimagined: Integrating services and innovation for accelerated clinical development
Wednesday, June 6, 2018 at 11am EDT
 Register now |
Elsevier, global information analytics business, carried out an analysis of the ability of animal studies to predict human safety. The study examined the consistency between preclinical animal testing and observations made in human clinical trials.
|
|
|
| Advertisement
Design of Early Phase Clinical Trials: How to Increase Efficiency and Probability of Success?
Europe: Tuesday, June 5, 2018 at 3pm CEST | 2pm BST
North America: Thursday, June 14, 2018 at 11am EDT | 10am CDT | 8am PDT
 Register now |
| Advertisement
Protein Biotherapeutic BioAnalysis, by Immunoaffinity LC-MS: Latest Trends and Recommendations
On Demand
 Learn more |
| Advertisement
Considerations when Addressing the Challenges of Time, Cost, and Data Standardization in Clinical Trials
On Demand
 Learn more |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
With technology's increasing ability to gather and analyze previously unmanageable data sets, and medicine's forays into genomics and targeted therapies, the time of the master protocol may be at hand.
| Advertisement
Operationalizing Gene Therapy Trials
On Demand
 Learn more |
Examining the unique standards and related challenges when assessing the safety and efficacy of cancer immunotherapy candidates.
| Advertisement
Medicine Use and Spending in the U.S. A Review of 2017 and Outlook to 2022
On Demand
 Learn more |
|
|
Blog Posts
In this interview, Munther Baara, Head of New Clinical Paradigms at Pfizer, will discuss his perspectives on how blockchain may impact clinical trials.
| Advertisement
Six Strategies for More Accurate Clinical Trial Forecasting & Budgeting
On Demand
 Learn more |
On Europe Day, the agency itself is right now keener than ever to assess its worth and the value of its services to Europe and to Europeans.
| Advertisement
Where Expertise Meets Nuance: Conducting PTSD Clinical Trials
On Demand
 Learn more |
|
|
RBM
Sponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.
|
|
CluePoints has launched the "CluePoints RBM and ICH E6 (R2) Starter Pack" to help small and medium-sized enterprises achieve regulatory compliance through a "risk-based" approach.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
